Intraperitoneal Administration of Fetuin-A Attenuates D-galactosamine/lipopolysaccharide-induced Liver Failure in Mouse
Overview
Authors
Affiliations
Background: Fulminant hepatic failure (FHF) is a devastating syndrome, which sometimes results in death or liver transplantation, in which inflammation would aggravate the development of fetuin-A which would act as an anti-inflammatory factor and may be an available approach to attenuate FHF.
Aims: The purpose of this study was to investigate the effects of fetuin-A on D-galactosamine/lipopolysaccharide (D-GalN/LPS)-induced liver failure in mice.
Methods: A mouse model of FHF induced by D-GalN/LPS was established and fetuin-A was injected intraperitoneally prior to D-GalN/LPS treatment. At different time points after D-GalN/LPS intervention, serum TNF-α and IL-6 levels were measured by ELISA. Fetuin-A mRNA and protein expression in liver tissues was assessed by RT-PCR, Western blotting and immunohistochemical staining. Besides, an observation of liver tissue injury, the apoptosis of hepatocytes, was analyzed by TUNEL assay.
Results: Expression of fetuin-A mRNA and protein in liver tissue were significantly and gradually decreased after D-GalN/LPS administration. A pre-intervention of exogenous fetuin-A significantly improved the liver function, decreased TNF-α and IL-6 expression in peripheral blood, and liver tissue inhibited hepatocyte apoptosis responded to D-GalN/LPS induction so as to decrease the mortality rates of FHF mouse. Meanwhile, fetuin-A was negatively correlated with the hepatic pathological score and TNF-α protein staining in FHF mouse.
Conclusions: An intraperitoneal injection of fetuin-A attenuates D-GalN/LPS-induced FHF in mice. Fetuin-A might be a protective agent of liver damage partly through inhibiting liver inflammatory response and hepatocyte apoptosis.
Mohamed M, Hussein M, Moustafa S, Rahmani Y, Ahmed Durrani T, Ali S Sci Rep. 2025; 15(1):1078.
PMID: 39775139 PMC: 11706989. DOI: 10.1038/s41598-025-85200-1.
Effect of fetuin-A on adenine-induced chronic kidney disease model in male rats.
Ashour W, Zamzam M, Sayed Ali H, Ebrahim R Iran J Basic Med Sci. 2023; 26(5):511-516.
PMID: 37051102 PMC: 10083833. DOI: 10.22038/IJBMS.2023.66346.14584.
Iacob S, Iacob D Front Endocrinol (Lausanne). 2022; 13:814209.
PMID: 35355551 PMC: 8959898. DOI: 10.3389/fendo.2022.814209.
El-Malkey N, Alsemeh A, Ashour W, Hassan N, Edrees H Exp Biol Med (Maywood). 2021; 246(11):1307-1317.
PMID: 33653159 PMC: 8371312. DOI: 10.1177/1535370221995207.
FGF23 and Fetuin-A Interaction in the Liver and in the Circulation.
Mattinzoli D, Ikehata M, Tsugawa K, Alfieri C, Dongiovanni P, Trombetta E Int J Biol Sci. 2018; 14(6):586-598.
PMID: 29904273 PMC: 6001652. DOI: 10.7150/ijbs.23256.